Trump: U.S. will respond with 'great force' if Iran attacks interests

Reuters | May 21, 2019

President Donald Trump warned on Monday Iran would be met with “great force” if it attacked U.S. interests in the Middle East, and government sources said Washington strongly suspects Shi’ite militias with ties to Tehran were behind a rocket attack in Baghdad’s Green Zone. “I think Iran would be making a very big mistake if they did anything,” Trump told reporters as he left the White House on Monday evening for an event in Pennsylvania. “If they do something, it will be met with great force but we have no indication that they will.” His comments came as two U.S. government sources said the United States strongly suspects Shi’ite militias with ties to, and possibly encouragement from, Iran fired a rocket on Sunday into Baghdad’s heavily fortified Green Zone.

Spotlight

Based on the 2016 Census of Agriculture and 2016 Census of Population, this infographic looks at the various aspect of the immigrant farm population including mother tongue and places of birth.

Spotlight

Based on the 2016 Census of Agriculture and 2016 Census of Population, this infographic looks at the various aspect of the immigrant farm population including mother tongue and places of birth.

Related News

GOVERNMENT BUSINESS

MilliporeSigma Announces $136.7 Million U.S. Government Contract Award for New Lateral Flow Membrane Production Facility in Sheboygan, Wisconsin

MilliporeSigma | December 30, 2021

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it has been awarded a $136.7M USD contract award for the construction of a lateral flow membrane production facility over a three-year period at the company's Sheboygan, Wisconsin site. The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness. "With this agreement, MilliporeSigma will construct a state-of-the-art lateral flow membrane production facility that will give our in vitro diagnostic (IVD) manufacturing customers greater flexibility and security of supply of our Hi-Flow™ Plus lateral flow membranes." Matthias Heinzel, Member of the Executive Board and CEO, Life Science, Merck KGaA, Darmstadt, Germany "Our lateral flow membranes have earned a reputation for high consistency among rapid diagnostic manufacturers and the already robust demand for this membrane has significantly increased since the onset of the pandemic. With this critical investment, we are expanding much-needed access to essential diagnostic testing as a trusted partner to the world's most sophisticated diagnostic manufacturers," said Jean-Charles Wirth, head of Applied Solutions, Life Science. Building this new facility supports the overall Life Science business sector's strategy to add physical capacity and expand its regional network to enable further growth of its key portfolios. Hi-Flow™ Plus Lateral flow membrane is used in rapid diagnostic test kit manufacturing by the Life Science business' customers, enabling reproducible results due to its consistent quality and optimized properties. The rapid test kits are used for a variety of applications, including Infectious Disease testing (Covid-19, HIV, Influenza, Malaria, etc.), as well as in women's health, biomarker detection, drug testing, food safety and animal health. Due to continuously increasing demand for lateral flow membrane, the Life Science business had already invested in a second membrane casting line in Cork, Ireland, which was recently completed, and expanded the range of other critical reagents (antibodies, beads, blockers, buffers) utilized to develop lateral flow rapid test kits. These strategic investments position the Life Science business as an important critical raw material supplier for the Diagnostic market, especially as the company prepares for IVD Regulation and Medical Device Regulation. The Life Science business is undertaking an ambitious, multi-year program to increase production capacity and capabilities to support the growing global demand for lifesaving vaccines, therapies and diagnostics. Within the last year, the company has accelerated investments to expand capacity to produce its support Mobius® single-use assemblies in both the U.S. and France, as well as increased capacity for the production of cell culture media in the U.S. and UK, among others. Additionally, several expansion projects continue to advance across the company's manufacturing and distribution global network. About the Life Science business of Merck KGaA, Darmstadt, Germany The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 23,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.

Read More

United States Air Force Selects Blackberry Spark for Their Secure Productivity

BlackBerry Limited | September 22, 2020

BlackBerry Limited announced today that the United States Air Force has selected BlackBerry Spark® for their secure productivity needs. The agreement gives the organization access to the latest BlackBerry technologies for Unified Endpoint Management (UEM) and Unified Endpoint Security (UES). BlackBerry Spark allows governments and enterprises to modernize their digital infrastructure, for high-performance 'work from anywhere', without any compromise on security. BlackBerry's secure productivity platform is powered by next-generation artificial intelligence and machine learning and unlocks the potential of connectivity across all deployment and endpoint types.

Read More

GOVERNMENT BUSINESS

Oracle Aconex for Defense Receives FedRAMP Moderate Authorization to Streamline Construction Project Management

Oracle | November 13, 2020

Oracle Aconex for Defense has gotten Federal Risk and Authorization Management Program (FedRAMP) Moderate approval. Presently, U.S. Branch of Defense (DoD) offices and their conveyance accomplices can utilize the answer for smooth out development venture the executives. Oracle Aconex for Defense is a high consistence security-endorsed example of Oracle Aconex, a protected cloud-based stage that improves venture coordinated effort by associating groups and data in a typical information climate (CDE). Oracle Aconex for Defense gives profoundly secure data the board, detailing, and work process mechanization to drive effectiveness, perceivability, and control across venture measures. FedRAMP gives a standard way to deal with security evaluation, approval, and constant checking for cloud items and administrations (CSPs) utilized by the U.S. National government and its accomplices. The U.S. Armed force Corps of Engineers (USACE) as of late gave the proper approval to utilization of Oracle Aconex for Defense. The arrangement is the main development venture data the board and cooperation programming to arrive at this accomplishment. The USACE's FedRAMP Moderate Authorization of Oracle Aconex for Defense signals our: Continued investment and commitment to providing purpose-built commercial off-the-shelf industry applications for federal defense agencies; and Support of the DoD's ongoing commitment to IT modernization in the cloud, data security, data management, and knowledge management, among other initiatives. "Our first FedRAMP authorization is a significant milestone for Oracle Construction and Engineering, as we are dedicated to providing cloud solutions to support the U.S. federal government's overarching goal of modernizing its technology infrastructure," said Mark Webster, senior vice president and general manager, Oracle Construction and Engineering. "We look forward to supporting the USACE and their customers, partners and sister agencies as they work together to deliver vital projects." About Oracle Construction and Engineering Asset owners and project leaders rely on Oracle Construction and Engineering solutions for the visibility and control, connected supply chain, and data security needed to drive performance and mitigate risk across their processes, projects, and organization. Our scalable cloud construction management software solutions enable digital transformation for teams that plan, build, and operate critical assets, improving efficiency, collaboration, and change control across the project lifecycle. About Oracle The Oracle Cloud offers a complete suite of integrated applications for Sales, Service, Marketing, Human Resources, Finance, Supply Chain and Manufacturing, plus Highly Automated and Secure Generation 2 Infrastructure featuring the Oracle Autonomous Database.

Read More